AtaiBeckley (ATAI) Other Non Operating Income (2020 - 2026)

AtaiBeckley (ATAI) recorded quarterly Other Non Operating Income of -$409000.0 in Q1 2026, down 189.69% quarter-over-quarter from $456000.0 in Q1 2025, and down 189.69% on a YoY basis from $456000.0 in Q1 2025.

AtaiBeckley (ATAI) Other Non Operating Income (2020 - 2026) Analysis & Trends

AtaiBeckley has disclosed Other Non Operating Income across 6 years of filings, most recently posting -$752000.0 for Q2 2025.

  • Other Non Operating Income for Q2 2025 came in at -$752000.0, down 716.39% year-over-year; the trailing twelve-month figure through Sep 2025 was -$2.0 million (down 1001.09% YoY), and the FY2024 annual result was -$1.3 million, down 568.25% from the prior year.
  • Other Non Operating Income was -$409000.0 for Q1 2026 at AtaiBeckley, down from $456000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $456000.0 in Q1 2025 to a low of -$409000.0 in Q1 2026.
  • The 5-year median for Other Non Operating Income is -$61500.0 (2023), against an average of $491714.3.
  • Peak annual rise in Other Non Operating Income reached 58845.45% in 2021, while the deepest fall reached 1392.57% in 2021.
  • AtaiBeckley's Other Non Operating Income stood at -$5.7 million in 2021, then jumped by 222.22% to $7.0 million in 2022, then slumped by 101.27% to -$89000.0 in 2023, then sank by 1319.1% to -$1.3 million in 2024, then jumped by 40.46% to -$752000.0 in 2025.
  • The last three Other Non Operating Income figures came in at -$752000.0 (Q2 2025), -$1.3 million (Q4 2024), and $122000.0 (Q2 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 AtaiBeckley 1.45 Bn 1.45 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 -409,000.00
Jun 30, 2025 -752,000.00
Mar 31, 2025 456,000.00
Dec 31, 2024 -1.26 Mn
Jun 30, 2024 122,000.00
Mar 31, 2024 -216,000.00
Dec 31, 2023 -89,000.00
Sep 30, 2023 -308,000.00
Jun 30, 2023 -34,000.00
Mar 31, 2023 243,000.00
Dec 31, 2022 7.01 Mn
Sep 30, 2022 -100,000.00
Jun 30, 2022 53,000.00
Dec 31, 2021 -5.74 Mn
Sep 30, 2021 6.46 Mn
Mar 31, 2021 1.49 Mn
Dec 31, 2020 444,000.00
Sep 30, 2020 -11,000.00
Jun 30, 2020 -37,000.00